RICE HALL JAMES & ASSOCIATES, LLC
Position in LGND — Ligand Pharmaceuticals Inc
CIK 1230765
San Diego, CA
Position in LGND
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$85,360,736
+$28,746,585 QoQ
Shares Held
270,052
-4.8% QoQ
Ownership
1.35%
of shares outstanding
% of Portfolio
4.18%
of 13F equity value
Holder Rank
#18
of 413 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 83%
Shared 0%
None 17%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RICE HALL JAMES & ASSOCIATES, LLC holds $259,930,953 across 19 Biotechnology names. LGND ranks #1 (32.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
This page
|
270,052 | $85,360,736 | |
| 2 | ASND |
Ascendis Pharma A/S
|
148,644 | $39,646,327 | |
| 3 | VRDN |
Viridian Therapeutics, Inc.\DE
|
1,175,906 | $21,601,393 | |
| 4 | ACAD |
Acadia Pharmaceuticals Inc
|
618,887 | $15,657,841 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
248,224 | $14,203,377 | |
| 6 | TSHA |
Taysha Gene Therapies, Inc.
|
1,992,229 | $13,567,079 | |
| 7 | MIRM |
Mirum Pharmaceuticals, Inc.
|
110,673 | $12,956,488 | |
| 8 | URGN |
UroGen Pharma Ltd.
|
300,650 | $11,063,920 |
All Filings in LGND
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $85,360,736 | 270,052 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $56,614,151 | 283,567 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $52,869,076 | 279,627 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $52,165,958 | 294,490 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $38,349,720 | 337,348 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $31,249,815 | 297,221 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $32,672,713 | 304,925 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $31,316,059 | 312,879 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $24,643,943 | 292,475 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $20,452,210 | 279,784 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $19,712,491 | 276,008 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $16,955,023 | 282,961 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $20,776,263 | 288,159 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $21,210,658 | 288,345 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $19,080,351 | 285,634 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $25,546,928 | 296,678 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $29,856,737 | 334,642 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $38,805,578 | 344,969 | Shares | Sole | 2022-05-26 | |
| 2021-12-31 | $53,705,570 | 347,699 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $52,066,646 | 373,720 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $49,685,064 | 378,726 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $65,562,015 | 430,056 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $50,138,592 | 504,159 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $36,841,748 | 386,506 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $37,105,107 | 331,740 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $24,606,680 | 338,376 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||